CN116286767A - Beta-caryophyllene synthetase, gene, strain and application - Google Patents
Beta-caryophyllene synthetase, gene, strain and application Download PDFInfo
- Publication number
- CN116286767A CN116286767A CN202310291537.7A CN202310291537A CN116286767A CN 116286767 A CN116286767 A CN 116286767A CN 202310291537 A CN202310291537 A CN 202310291537A CN 116286767 A CN116286767 A CN 116286767A
- Authority
- CN
- China
- Prior art keywords
- caryophyllene
- beta
- recombinant expression
- gene
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- NPNUFJAVOOONJE-ZIAGYGMSSA-N trans-caryophyllene Natural products C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 title claims abstract description 91
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 title claims abstract description 50
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 title claims abstract description 50
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 24
- 102000003960 Ligases Human genes 0.000 title claims abstract description 11
- 108090000364 Ligases Proteins 0.000 title claims abstract description 11
- 101710137820 Beta-caryophyllene synthase Proteins 0.000 claims abstract description 14
- 108090000790 Enzymes Proteins 0.000 claims abstract description 6
- 102000004190 Enzymes Human genes 0.000 claims abstract description 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 4
- 239000002304 perfume Substances 0.000 claims abstract description 4
- 238000003259 recombinant expression Methods 0.000 claims description 23
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 17
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 17
- 239000013604 expression vector Substances 0.000 claims description 16
- 239000012634 fragment Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 108091008146 restriction endonucleases Proteins 0.000 claims description 5
- 239000013598 vector Substances 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 238000001976 enzyme digestion Methods 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
- 102000012410 DNA Ligases Human genes 0.000 claims description 2
- 108010061982 DNA Ligases Proteins 0.000 claims description 2
- 238000003776 cleavage reaction Methods 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000007017 scission Effects 0.000 claims description 2
- 239000000686 essence Substances 0.000 claims 1
- 239000012450 pharmaceutical intermediate Substances 0.000 claims 1
- 238000000855 fermentation Methods 0.000 abstract description 8
- 230000004151 fermentation Effects 0.000 abstract description 8
- 244000043261 Hevea brasiliensis Species 0.000 abstract description 7
- 230000037361 pathway Effects 0.000 abstract description 5
- 239000013612 plasmid Substances 0.000 abstract description 4
- 230000002194 synthesizing effect Effects 0.000 abstract description 3
- 229910000831 Steel Inorganic materials 0.000 abstract description 2
- 239000010959 steel Substances 0.000 abstract description 2
- 108700026220 vif Genes Proteins 0.000 abstract description 2
- KJTLQQUUPVSXIM-ZCFIWIBFSA-M (R)-mevalonate Chemical compound OCC[C@](O)(C)CC([O-])=O KJTLQQUUPVSXIM-ZCFIWIBFSA-M 0.000 abstract 1
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 abstract 1
- 101710125754 Farnesyl pyrophosphate synthase Proteins 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 244000223014 Syzygium aromaticum Species 0.000 description 4
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006801 homologous recombination Effects 0.000 description 3
- 238000002744 homologous recombination Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229930004725 sesquiterpene Natural products 0.000 description 3
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 239000007222 ypd medium Substances 0.000 description 2
- QCESRPKOTSPFAU-VHDGCEQUSA-N (1R,4R,5S)-(-)-guaia-6,10(14)-diene Chemical compound CC(C)C1=C[C@@H]2[C@H](C)CC[C@H]2C(=C)CC1 QCESRPKOTSPFAU-VHDGCEQUSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- IAFUZCLDORRBJY-UHFFFAOYSA-N 2-piperidin-4-yloxypyrimidine Chemical compound C1CNCCC1OC1=NC=CC=N1 IAFUZCLDORRBJY-UHFFFAOYSA-N 0.000 description 1
- 241001647745 Banksia Species 0.000 description 1
- 101100025317 Candida albicans (strain SC5314 / ATCC MYA-2876) MVD gene Proteins 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 101150051269 ERG10 gene Proteins 0.000 description 1
- 101150071502 ERG12 gene Proteins 0.000 description 1
- 101150014913 ERG13 gene Proteins 0.000 description 1
- 101150084072 ERG20 gene Proteins 0.000 description 1
- 101150045041 ERG8 gene Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101001081533 Homo sapiens Isopentenyl-diphosphate Delta-isomerase 1 Proteins 0.000 description 1
- 102100027665 Isopentenyl-diphosphate Delta-isomerase 1 Human genes 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 101150079299 MVD1 gene Proteins 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 101100445407 Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) erg10B gene Proteins 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- PHIQHXFUZVPYII-UHFFFAOYSA-N carnitine Chemical compound C[N+](C)(C)CC(O)CC([O-])=O PHIQHXFUZVPYII-UHFFFAOYSA-N 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 201000010897 colon adenocarcinoma Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229930185143 englerin Natural products 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 229940026778 other chemotherapeutics in atc Drugs 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- -1 tHMG1 Proteins 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 108010087432 terpene synthase Proteins 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- VLCQZHSMCYCDJL-UHFFFAOYSA-N tribenuron methyl Chemical compound COC(=O)C1=CC=CC=C1S(=O)(=O)NC(=O)N(C)C1=NC(C)=NC(OC)=N1 VLCQZHSMCYCDJL-UHFFFAOYSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/202—Aliphatic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P5/00—Preparation of hydrocarbons or halogenated hydrocarbons
- C12P5/007—Preparation of hydrocarbons or halogenated hydrocarbons containing one or more isoprene units, i.e. terpenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/03—Carbon-oxygen lyases (4.2) acting on phosphates (4.2.3)
- C12Y402/03057—Beta-caryophyllene synthase (4.2.3.57)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/85—Saccharomyces
- C12R2001/865—Saccharomyces cerevisiae
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses beta-caryophyllene synthetase, a gene, a strain and application. The invention discovers for the first time that the enzyme with the amino acid sequence shown in SEQ ID NO.1, which is derived from rubber tree Hevea brasiliensis, is the synthetase of beta-caryophyllene, and the synthetase or the coding gene thereof or the recombinant plasmid and the recombinant strain containing the coding gene thereof can be used for synthesizing or producing the beta-caryophyllene. The invention provides a beta-caryophyllene high-yield strain, which is obtained by introducing a coding gene of beta-caryophyllene synthase into a microorganism which overexpresses one or more genes in a mevalonate pathway and a farnesyl pyrophosphate synthase gene, and the yield of a fermentation tank (5L steel tank) of the beta-caryophyllene high-yield strain is up to 6.2g/L. The prepared beta-caryophyllene can be used for preparing perfume, essence and medical intermediates.
Description
Technical Field
The invention belongs to the technical field of genetic engineering, and particularly relates to beta-caryophyllene synthetase, a gene, a strain and application.
Background
Beta-caryophyllene belongs to a member of a terpenoid family, is a sesquiterpene, has spicy, banksia rose, citrus, camphor and mild clove fragrance, and mainly exists in plants such as ginseng, clove flowers and the like. Beta-caryophyllene was approved by state GB2760-1996 as a food flavor for use. At present, the method is mainly used for preparing the edible essence such as clove, pepper, nutmeg, orange, herb and the like, and can also be used for synthesizing more valuable spices such as acetyl caryophyllene and the like. In addition to being used as a perfume substance, the research on the biological activity of the beta-caryophyllene shows that the beta-caryophyllene has various biological activities such as anticancer, anti-inflammatory, antioxidation, nerve protection and the like. Beta-caryophyllene not only has anticancer activity by itself, but also can remarkably improve the anticancer activity of other chemotherapeutics by increasing the permeability of cell membranes. For example, β -caryophyllene increases the permeability of paclitaxel to cell membranes, increasing its inhibitory activity on colon adenocarcinoma cell DLD-1 by a factor of 10. The main production mode of the beta-caryophyllene at present is that the beta-caryophyllene is obtained from clove oil through vacuum fractionation, the biotechnological synthesis of the beta-caryophyllene is still in a starting stage, the yield is low, the industrialization level cannot be reached far, and the research on the biosynthesis of the beta-caryophyllene has important research significance and has further development value.
Disclosure of Invention
The invention aims at providing beta-caryophyllene synthetase, gene, strain and application aiming at the defects of the prior art.
In order to achieve the above purpose, the present invention adopts the following technical scheme:
the first object of the invention is to provide a beta-caryophyllene synthase HbBaS, the amino acid sequence of which is shown as SEQ ID NO. 1.
A second object of the present invention is to provide an application of a β -caryophyllene synthase gene HbBACS in the synthesis or production of β -caryophyllene, wherein the base sequence of the β -caryophyllene synthase gene HbBACS is identical to the nucleotide sequence of SEQ ID NO:2 has a nucleotide sequence having an identity of 95% or more.
Further, the base sequence of the beta-caryophyllene synthase gene HbBACS is shown as SEQ ID NO: 2.
The third object of the present invention is to provide a recombinant expression vector comprising the above-mentioned beta-caryophyllene synthase gene HbBACS.
The fourth object of the present invention is to provide a method for constructing the recombinant expression vector, comprising the following steps: adding restriction sites to the gene HbBACS of any one of claims 2 to 3, and then performing double restriction with restriction enzymes Sal I and Xho I, respectively, to obtain a gene HbBACS fragment having a sticky end; the commercial expression vector pRS426 of the saccharomyces cerevisiae is subjected to double enzyme digestion by restriction enzymes Pme I and Not I respectively to obtain a vector pRS426 fragment with a sticky end; and connecting the gene HbBACS fragment with the sticky end and the vector pRS426 fragment with the sticky end through T4 DNA ligase to obtain the beta-caryophyllene synthase recombinant expression vector pHbBACS.
It is a fifth object of the present invention to provide a recombinant expression strain comprising the recombinant expression vector described above.
Further, the host cell of the recombinant expression strain is Saccharomyces cerevisiae.
The sixth object of the present invention is to provide a method for preparing the recombinant expression strain, wherein the recombinant expression vector pHbBACS of beta-caryophyllene synthetase is linearized through an enzyme cleavage site; the linearized recombinant expression vector pHbBACS is introduced into a host cell to obtain a recombinant expression strain.
A seventh object of the present invention is to provide a method for producing β -caryophyllene, culturing the recombinant expression strain as described above, and obtaining β -caryophyllene from the culture.
An eighth object of the present invention is to provide the use of the above-mentioned β -caryophyllene for the preparation of fragrances or perfumes.
Compared with the prior art, the technical scheme provided by the invention has the beneficial effects that:
(1) The invention discovers the beta-caryophyllene synthetase derived from rubber tree and the coding gene thereof for the first time, and the enzyme can efficiently synthesize the product beta-caryophyllene.
(2) The constructed beta-caryophyllene high-yield strain has a shake flask yield of 126mg/L and a fermentation tank (5L steel tank) yield of 6.2g/L, thus laying a solid foundation for the industrial application of the beta-caryophyllene for the highest yield reported at present.
Drawings
FIG. 1 is a graph showing the results of GC-MS detection of the JBS1 strain products of the present invention;
FIG. 2 is a diagram of a rubber tree latex used in the present invention.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the following detailed description of the specific embodiments of the present invention will be given with reference to the accompanying drawings. The examples are not to be construed as limiting the specific techniques or conditions described in the literature in this field or as per the specifications of the product. The reagents or apparatus used were conventional products commercially available without the manufacturer's attention.
Taq DNA polymerase, restriction enzyme, plasmid extraction kit and DNA extraction kit were all purchased from Takara company; the DNA gel recovery kit was purchased from nuvazan company; homologous recombination kits were purchased from assist san Co; expression plasmid pRS426 was purchased from ATCC; the specific gene primer pair P1/P2 was synthesized by Jin Kairui.
The detection method of the beta-caryophyllene comprises the following steps: the organic phase of the two-phase fermentation culture was collected, centrifuged at 3500rpm for 10 minutes to remove cell debris, and diluted with n-hexane to an appropriate range. The samples were then subjected to gas chromatography mass spectrometry (GC-MS) detection analysis, using a TSQ QUANTUM XLS mass spectrometer (Thermo Fisher Scientific, thermo, MA, USA), and the concentration of beta-caryophyllene was detected and quantified using a TR-5MS column (30 m 0.25mm 0.25 μm). The GCMS program was set as follows: the temperature was initially maintained at 50 ℃ for 1 minute, then increased to 280 ℃ at a rate of 15 ℃/minute for 1 minute, then increased to 300 ℃ at a rate of 20 ℃/minute for 2 minutes. Compounds were determined by comparison with standard β -caryophyllene from Sigma-Aldrich (St.Louis, MO, U.S.A.) or by comparison of NIST (National Institute of Standards and Technology) database and retention index;
YPD medium: the medium fraction contained 2% glucose (Country), 2% tryptone (Angel Yeast FP 318), 1% Yeast extract (Angel Yeast FM 888)
Yeast strain YZL141, the construction method of which is described in Shi Bin et al, "Systematic Metabolic Engineering of Saccharomyces cerevisiae for Lycopene Overproduction," Journal of agricultural and food chemistry vol.67,40 (2019): 11148-11157.Doi:10.1021/acs. Jafc.9b04519.
Yeast strain JCR27, the construction method of which is described in Siemon, thomas et al, "Semisynthesis of Plant-Derived Englerin AEnabled by Microbe Engineering of Guaia-6,10 (14) -diene as Building Block." Journal of the American Chemical Society vol.142,6 (2020): 2760-2765.Doi:10.1021/jacs.9b12940.
Rubber tree cDNA: RNA extracted from rubber tree latex (as shown in FIG. 2) is then reverse transcribed into cDNA, and the process is usually performed under conventional conditions such as those described in the publication of the scientific Press (fourth edition) or according to the conditions suggested by the manufacturer, which are well known to those skilled in the art, and the present invention is not limited thereto.
Example 1
(1) Recombinant vector construction
The applicant analyzes the genome of the rubber tree and discovers a terpene synthase HbBaS, the amino acid sequence of which is shown as SEQ ID NO.1, and the nucleotide sequence of which is shown as SEQ ID NO. 2.
The specific gene primer pair P1/P2 (shown in Table 1) is designed, rubber tree cDNA is used as a template, a specific gene fragment is obtained through PCR amplification by using Prime STAR MAX PCR enzyme of Takara company, the fragment is recovered by using a Novain gum recovery kit, then the fragment is connected to a yeast commercial expression vector pRS426 (Sal I/Xho I) through a homologous recombination method by using a holy Corp homologous recombination kit, and after sequencing and confirmation, a yeast expression vector containing the specific gene HbBACS is obtained and named pHbBACS.
Table 1.
(2) Strain construction
The pHbBACS plasmid was transformed into the Yeast strain YZL141 competence by PEG/LiAC method, spread on SD-URA screening plate, cultured for 3d, and then colony PCR verification was performed using the Noruzbac PCR reagent using the P1 and P2 primers, and the positive bacteria was named YHbBACS. The strain YHbBACS is a plasmid which firstly strengthens the MVA pathway based on Saccharomyces cerevisiae CEN.PK2-1D, overexpresses the speed-limiting enzyme tHMG1 of the MVA pathway and is transformed into a specific gene HbBACS.
Meanwhile, the HbBACS gene fragment is recovered by utilizing the enzyme digestion pHbBACS of PmeI, the fragment is introduced into the competent yeast strain JCR27 by a PEG/LiAC method, and the positive bacteria are named as JBS1 after the PCR verification of the yeast colony. Compared with CEN.PK2-1D strain, the strain JBS1 strengthens MVA pathway, over-expresses the whole MVA pathway, and over-expresses HbBACS genes on the basis, wherein the copy numbers of the genes in the strain JBS1 are ERG10, ERG13, tHMG1, ERG12, ERG8, MVD1, IDI1, ERG20, hbBACS=2, 2 and 1.
(3) Shaking flask fermentation
The YHbBACS strain was inoculated into 50mL of YPD medium supplemented with 1% galactose, 1% IPM was added, and after 3d incubation at 30℃the organic oil phase of the coating was collected by centrifugation at 8000rpm for 10min and diluted with n-hexane to the appropriate range for GC-MS detection. The main peak is compared with the retention time of a beta-caryophyllene standard substance and MS data, so that the strain YHbBACS can be determined to synthesize beta-caryophyllene, the gene HbBACS is a beta-caryophyllene synthase gene, and the shake flask yield is 18mg/L; the small peak product is compared with NIST database, and the product is alpha-humulone.
The JBS1 strain was similarly fermented for 72 hours after adding 10% isopropyl myristate (IPM) cover, centrifuged to obtain an organic oil phase, and diluted with n-hexane to an appropriate range for GC-MS detection. The yield of the sesquiterpene product β -caryophyllene increased from 18mg/L of strain YHbBACS to 126mg/L of strain JBS1 by about 7-fold.
The strain JBS1 thus constructed was fed-batch fermented with the addition of a covering agent during the fermentation to effect in situ extraction, the covering agent being IPM isopropyl myristate, as described in reference (van Hoek, P.; de Hulster, E.; van Dijken, J.P.; ink, J.T. commercial capability in high-cell-density fed-batch cultures of baker's yeast. Biotechnol. Bioeng.2000,68, 517-523.). The dissolved oxygen is controlled to be more than 20 percent in the fermentation process, the pH value is 5, the glucose concentration is 1-2g/L, and the ethanol concentration is less than 5 g/L. Finally, on a fermentation tank (5L fermentation tank), the yield of the sesquiterpene product beta-caryophyllene reaches 6.2g/L.
Example 2
To evaluate the potential value of β -caryophyllene as a fragrance and flavoring, the aroma in this molecule was analyzed by a cosmonautic engineer, with β -caryophyllene having spicy, woody, citrus, camphorous, mild clove aromas. When β -caryophyllene is heated, white smoke is produced with an enhanced odor, indicating its potential for use as a flavor ingredient and food flavoring.
Those skilled in the art know that beta-caryophyllene has been specified by national standard GB 2670-1996 as a permissible edible spice which can be used for daily chemicals of spicy type and the flavoring of edible essence, and for the coordination of tobacco essence, and the beta-caryophyllene has a better effect on increasing the burnt sweet smell.
Example 3
The organic covering phase obtained by fermenting and collecting the recombinant saccharomyces cerevisiae constructed by the new beta-caryophyllene synthase gene of the invention is used for distinguishing different components in a rectification way, the purity of the purified beta-caryophyllene can reach more than 95 percent, the purified beta-caryophyllene can be used as a medical intermediate by fermenting and collecting the purified beta-caryophyllene and can be used as a raw material medicine for continuously synthesizing other medicines,
the embodiments described above and features of the embodiments herein may be combined with each other without conflict.
The foregoing description of the preferred embodiments of the invention is not intended to limit the invention to the precise form disclosed, and any such modifications, equivalents, and alternatives falling within the spirit and scope of the invention are intended to be included within the scope of the invention.
Claims (10)
1. A beta-caryophyllene synthase HbBaS, characterized by: the amino acid sequence of the beta-caryophyllene synthetase HbBaS is shown as SEQ ID NO. 1.
2. An application of a beta-caryophyllene synthase gene HbBACS in synthesis or production of beta-caryophyllene, which is characterized in that the base sequence of the beta-caryophyllene synthase gene HbBACS is identical with the base sequence of SEQ ID NO:2 has a nucleotide sequence having an identity of 95% or more.
3. The use according to claim 2, wherein the base sequence of the β -caryophyllene synthase gene HbBACS is as set forth in SEQ ID NO: 2.
4. A recombinant expression vector comprising the gene HbBACS of any one of claims 2-3.
5. The method for constructing a recombinant expression vector according to claim 4, comprising the steps of: adding restriction sites to the gene HbBACS of any one of claims 2 to 3, and then performing double restriction with restriction enzymes Sal I and Xho I, respectively, to obtain a gene HbBACS fragment having a sticky end; the commercial expression vector pRS426 of the saccharomyces cerevisiae is subjected to double enzyme digestion by restriction enzymes Pme I and Not I respectively to obtain a vector pRS426 fragment with a sticky end; and connecting the gene HbBACS fragment with the sticky end and the vector pRS426 fragment with the sticky end through T4 DNA ligase to obtain the beta-caryophyllene synthase recombinant expression vector pHbBACS.
6. A recombinant expression strain comprising the recombinant expression vector of claim 5.
7. The recombinant expression strain of claim 6, wherein the host cell of the recombinant expression strain is saccharomyces cerevisiae.
8. A method of preparing a recombinant expression strain according to claim 6 or 7, comprising the steps of: linearizing a recombinant expression vector pHbBACS of the beta-caryophyllene synthetase through enzyme cleavage sites; the linearized recombinant expression vector pHbBACS is introduced into a host cell to obtain a recombinant expression strain.
9. A method for producing beta-caryophyllene is characterized in that: culturing the recombinant expression strain of claim 6 or 7, and obtaining β -caryophyllene from the culture.
10. Use of a β -caryophyllene according to claim 9 for the preparation of a perfume or essence or pharmaceutical intermediate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310291537.7A CN116286767B (en) | 2023-03-21 | 2023-03-21 | Beta-caryophyllene synthetase, gene, strain and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310291537.7A CN116286767B (en) | 2023-03-21 | 2023-03-21 | Beta-caryophyllene synthetase, gene, strain and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116286767A true CN116286767A (en) | 2023-06-23 |
CN116286767B CN116286767B (en) | 2023-12-19 |
Family
ID=86786814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310291537.7A Active CN116286767B (en) | 2023-03-21 | 2023-03-21 | Beta-caryophyllene synthetase, gene, strain and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116286767B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117467626A (en) * | 2023-10-31 | 2024-01-30 | 武汉软件工程职业学院(武汉开放大学) | Beta-olivine synthetase, gene and application thereof |
CN117604006A (en) * | 2023-10-24 | 2024-02-27 | 中国热带农业科学院橡胶研究所 | Hedycaryol synthetase gene of rubber tree and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104120141A (en) * | 2014-07-14 | 2014-10-29 | 青岛农业大学 | A method of synthesizing beta-caryophyllene by microbial catalysis and a reconstituted cell capable of synthesizing the beta-caryophyllene |
CN111004763A (en) * | 2019-12-26 | 2020-04-14 | 中国科学院青岛生物能源与过程研究所 | Engineering bacterium for producing β -caryophyllene and construction method and application thereof |
-
2023
- 2023-03-21 CN CN202310291537.7A patent/CN116286767B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104120141A (en) * | 2014-07-14 | 2014-10-29 | 青岛农业大学 | A method of synthesizing beta-caryophyllene by microbial catalysis and a reconstituted cell capable of synthesizing the beta-caryophyllene |
CN111004763A (en) * | 2019-12-26 | 2020-04-14 | 中国科学院青岛生物能源与过程研究所 | Engineering bacterium for producing β -caryophyllene and construction method and application thereof |
Non-Patent Citations (3)
Title |
---|
GENBANK: KAF2285869.1: "hypothetical protein GH714_008546 [Hevea brasiliensis]", 《GENBANK》 * |
JIAHAO LIANG等: "In Silico Genome-Wide Mining and Analysis of Terpene Synthase Gene Family in Hevea Brasiliensis", 《BIOCHEMICAL GENETICS》, vol. 61, no. 3, pages 1185 - 1209 * |
申海燕等: "青蒿倍半萜合酶(环化酶)研究进展", 《生物工程学报》, vol. 23, no. 6, pages 976 - 981 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117604006A (en) * | 2023-10-24 | 2024-02-27 | 中国热带农业科学院橡胶研究所 | Hedycaryol synthetase gene of rubber tree and application thereof |
CN117604006B (en) * | 2023-10-24 | 2024-05-17 | 中国热带农业科学院橡胶研究所 | Rubber tree Hedycaryol synthetase gene and application thereof |
CN117467626A (en) * | 2023-10-31 | 2024-01-30 | 武汉软件工程职业学院(武汉开放大学) | Beta-olivine synthetase, gene and application thereof |
CN117467626B (en) * | 2023-10-31 | 2024-05-31 | 武汉软件工程职业学院(武汉开放大学) | Beta-olivine synthetase, gene and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN116286767B (en) | 2023-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN116286767B (en) | Beta-caryophyllene synthetase, gene, strain and application | |
CN101384719B (en) | Method for producing terpenes and MEP-transformed microorganisms therefore | |
CN104017794B (en) | Method for producing (+)-khusene | |
CN109666668B (en) | Small sepal moss sesquiterpene synthetase MTa and gene sequence thereof | |
CN102245778B (en) | Method for producing beta-santalene | |
CN109370927A (en) | Candidiasis FW922-1 and its application | |
CN111690690B (en) | Saccharomyces cerevisiae for producing farnesene | |
CN116064264A (en) | Method for producing recombinant host cells with improved tolerance to terpenes or essential oils containing terpenes and uses thereof | |
CN106987531B (en) | Wine membrana tectoria yeast and application thereof in monoterpene production | |
ul Hassan et al. | Engineered Saccharomyces cerevisiae for the de novo synthesis of the aroma compound longifolene | |
Hong et al. | The proportion of non-aflatoxigenic strains of the Aspergillus flavus/oryzae complex from meju by analyses of the aflatoxin biosynthetic genes | |
CN109810999A (en) | A method of nerol is produced using microbial fermentation | |
KR101839996B1 (en) | Method for mass production of sesquiterpene from Polyporus brumalis | |
CN104736708A (en) | Method for producing terpenes | |
CN106244615B (en) | Engineering bacterium, construction method thereof and application of engineering bacterium in preparation of geraniol | |
CN102071155A (en) | High-yield s-linalool genetic engineering strain and building method thereof | |
CN115873836B (en) | Nerolidol synthetase and application | |
CN107304407A (en) | Medical grade anticancer novelty Antrodia camphorata bacterial strain | |
CN113621633B (en) | Mangifera indica terpene synthase gene TPS1 and application thereof | |
CN109679943A (en) | A kind of Celastrus angulatus sesquiterpene synthase CaTPS3 and its gene order | |
CN112300944B (en) | Hordeum radiobacter strain and application thereof in preparation of fragrant substances | |
CN109852600B (en) | Small sepal moss sesquiterpene synthetase MTb and gene sequence thereof | |
Makopa et al. | The marula and elephant intoxication myth: assessing the biodiversity of fermenting yeasts associated with marula fruits (Sclerocarya birrea) | |
CN109837266B (en) | Small sepal moss sesquiterpene synthetase MTc and gene sequence thereof | |
CN117467626B (en) | Beta-olivine synthetase, gene and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |